Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) Research & Development (2019 - 2025)

Historic Research & Development for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to -$10186.0.

  • Evotec SE's Research & Development rose 2188.82% to -$10186.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $128.2 million, marking a year-over-year increase of 7369.95%. This contributed to the annual value of $54.3 million for FY2024, which is 2629.42% down from last year.
  • Evotec SE's Research & Development amounted to -$10186.0 in Q3 2025, which was up 2188.82% from $54.4 million recorded in Q4 2024.
  • In the past 5 years, Evotec SE's Research & Development registered a high of $82.5 million during Q4 2021, and its lowest value of -$22267.1 during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $4224.5 (2022), whereas its average is $20.6 million.
  • As far as peak fluctuations go, Evotec SE's Research & Development surged by 3254.66% in 2023, and later crashed by 16843.99% in 2024.
  • Evotec SE's Research & Development (Quarter) stood at $82.5 million in 2021, then dropped by 5.33% to $78.1 million in 2022, then fell by 5.57% to $73.8 million in 2023, then dropped by 26.29% to $54.4 million in 2024, then crashed by 100.02% to -$10186.0 in 2025.
  • Its Research & Development stands at -$10186.0 for Q3 2025, versus $54.4 million for Q4 2024 and -$13040.3 for Q3 2024.